Literature DB >> 9363413

Polydrug dependence and psychiatric comorbidity among heroin injectors.

S Darke1, J Ross.   

Abstract

The prevalence of diagnoses of substance dependence, anxiety disorders and depressive disorders were estimated in a sample of 222 heroin injectors, using the Composite International Diagnostic Interview. Subjects had a median of three lifetime substance diagnoses and two current diagnoses. A total of 60% met the criteria for a lifetime anxiety disorder, and 51% had a current anxiety disorder. A depressive disorder was diagnosed in 41% of subjects, with 30% having a current diagnosis. There were significant positive correlations between the number of lifetime drug dependence diagnoses and the number of lifetime anxiety and affective disorders (r = 0.41), and the number of current drug dependence diagnoses and the number of current comorbid diagnoses (r = 0.32). After controlling for other variables, the only significant independent predictor of the number of lifetime and current dependence diagnoses was the number of comorbid diagnoses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9363413     DOI: 10.1016/s0376-8716(97)00117-8

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  33 in total

1.  Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection.

Authors:  Maryam Alavi; Jason Grebely; Gail V Matthews; Kathy Petoumenos; Barbara Yeung; Carolyn Day; Andrew R Lloyd; Ingrid Van Beek; John M Kaldor; Margaret Hellard; Gregory J Dore; Paul S Haber
Journal:  J Gastroenterol Hepatol       Date:  2012-05       Impact factor: 4.029

2.  Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment.

Authors:  Jonathan D Savant; Declan T Barry; Christopher J Cutter; Michelle T Joy; An Dinh; Richard S Schottenfeld; David A Fiellin
Journal:  Drug Alcohol Depend       Date:  2012-07-06       Impact factor: 4.492

3.  Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study).

Authors:  Benedikt Fischer; Jürgen Rehm; Suzanne Brissette; Serge Brochu; Julie Bruneau; Nady El-Guebaly; Lina Noël; Mark Tyndall; Cameron Wild; Phil Mun; Dolly Baliunas
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

Review 4.  Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS.

Authors:  L Degenhardt; W Hall; M Warner-Smith
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

5.  Psychiatric and substance use disorders among methadone maintenance patients with chronic hepatitis C infection: effects on eligibility for hepatitis C treatment.

Authors:  Steven L Batki; Kelly M Canfield; Robert Ploutz-Snyder
Journal:  Am J Addict       Date:  2011-05-31

6.  Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014.

Authors:  Natalie A Blackburn; Rajiv C Patel; Jon E Zibbell
Journal:  Public Health Rep       Date:  2016 May-Jun       Impact factor: 2.792

7.  Risk factors for heroin use following release from jail or prison in adults in a Central Appalachian state between 2012-2017.

Authors:  Kirsten Elin Smith; Adrian Archuleta; Michele Staton; Erin Winston
Journal:  Am J Drug Alcohol Abuse       Date:  2020-04-03       Impact factor: 3.829

8.  Gender and comorbidity among individuals with opioid use disorders in the NESARC study.

Authors:  Christine E Grella; Mitchell P Karno; Umme S Warda; Noosha Niv; Alison A Moore
Journal:  Addict Behav       Date:  2009-01-30       Impact factor: 3.913

9.  Are non-fatal opioid overdoses misclassified suicide attempts? Comparing the associated correlates.

Authors:  Elizabeth Maloney; Louisa Degenhardt; Shane Darke; Elliot C Nelson
Journal:  Addict Behav       Date:  2009-05-03       Impact factor: 3.913

10.  Predictors of active injection drug use in a cohort of patients infected with hepatitis C virus.

Authors:  Carrie Reed; Caleb Bliss; Sherri O Stuver; Timothy Heeren; Sheila Tumilty; C Robert Horsburgh; Jeffrey H Samet; Deborah J Cotton
Journal:  Am J Public Health       Date:  2012-11-15       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.